A research study from Vienna has reported that bacteriophages found in the skin microbiome of patients with AD may lead to the...

Findings from a cross-sectional study of survey data suggest that U.S. sexual and gender minority (SGM) patients with chronic...

Colloidal oatmeal 1% is efficacious in treating mild-to-moderate AD in Black children, according to a recent study.

Dr. Vimal Prajapati reports on common molecular signatures of chronic hand eczema at the 2023 EADV Congress in Berlin.

Dr. Vimal Prajapati reports about tapinarof 1% cream for treating severe AD at the 2023 EADV Congress in Berlin.

Dr. Mark Kirchhof reports late breakers presentations around atopic dermatitis and prurigo nodularis from the 2023 EADV Congress in Berlin.

Dupilumab successfully decreases IgE serum levels in AD patients regardless of dosing intervals, according to a recent study.

New research shows that adults with atopic dermatitis (AD) have a 34% increased risk of developing new-onset inflammatory bowel disease...